medline.ch Onkologie Urologische Tumoren

	Detecting clinically significant prostate cancer with a distributed parameter model based on quantitative dynamic contrast-enhanced magnetic resonance imaging. Quant Imaging Med Surg Zhang H, Du J, Lei J, Wu K, Hou Z, Lei L, Wang B. PMID: 42433525 [PubMed]
	The value of [(18)F]PSMA-1007 PET/CT combined with mpMRI in diagnosing prostate cancer with PI-RADS 3-4 lesions. Quant Imaging Med Surg Shui R, Li J, Ge S, Cao J, Deng S, Zhang B. PMID: 42433522 [PubMed]
	The ITALIC-RCC: A Randomized Trial on Clinical and Humoral Impact of Primary Tumor Ablation by Surgery or Radiotherapy in Metastatic Renal Cell Carcinoma Treated with Checkpoint Inhibitors. Eur Urol Open Sci Iacovelli R, Ciccarese C, Arduini D, Tagliaferri L, Minervini A, Simone G, Ficarra V, Porta C, Calabrò F, Zucali P, Troisi P, Francolini G, Morganti AG, Franzese C, Jereczek-Fossa BA, Maria Rocco BC. PMID: 42433301 [PubMed]
	Histopathological Advantages of En Bloc Resection in Non-muscle-invasive Bladder Cancer: A Multinational Randomised Controlled Clinical Trial. Eur Urol Open Sci Nielsen NK, Milling RV, Hjort PB, Vásquez JL, Haug ES, Sørensen FE, Olsen KØ, Fabrin K, Vjaters E, Rudlang TM, Sepp T, Nurminen P, Geertsen L, Lam GW, Jakobsen JK, Graugaard-Jensen C, Stifter-Vretenar S, Jensen JB, Kingo PS. PMID: 42433300 [PubMed]
	Mental health disorders following nephrectomy for renal cell carcinoma: a national study. BJU Int Esen B, Lahiji R, Patil D, Mumford S, Landrum KR, Nabavizadeh R, Hajiha M, Grajales V, Khater N, Joshi SS, Narayan VM, Ogan K, Master VA. PMID: 42433145 [PubMed - as supplied by publisher]
	Exploring the response shift effects on patient-reported outcomes among postoperative bladder cancer patients: a qualitative study in China. BMC Urol Kang Y, Zhong G, Zhang Y, Chang Z, Wang T, Huang M, Gao R, Li N, Lv A. PMID: 42432550 [PubMed - as supplied by publisher]
	Ultrahypofractionation of localized prostate cancer-an updated statement of the prostate cancer working group of the German Society of Radiation Oncology (DEGRO). Strahlenther Onkol Müller AC, Aebersold DM, Albrecht C, Boehmer D, Ganswindt U, Schmidt-Hegemann NS, Höcht S, Hoffmann E, Hölscher T, Koerber SA, Niehoff P, Peeken JC, Pinkawa M, Polat B, Shelan M, Spohn SKB, Wolf F, Zamboglou C, Zips D, Wiegel T. PMID: 42432214 [PubMed - as supplied by publisher]
	Cognitive Versus Software-based Fusion Targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION). Eur Urol He BM, Zhang K, Zhou Z, Chen X, Liu Y, Dong B, Wang Y, Xing Y, He W, Jin Z, Zhang T, Feng T, Liang L, Chen B, Chen S, Lu Z, Zhou S, Zhao Y, Liu Y, Wang Z, Na R, Zhang X, Shi B, Wang HF, IMAGINATION Group. PMID: 42431755 [PubMed - as supplied by publisher]
	Adjuvant penpulimab in very-high risk clear cell renal cell carcinoma: a prospective, non-randomized, controlled phase II trial with integrated plasma multi-omics analyses. J Immunother Cancer Wang Y, Wang D, Zhao H, Zhou Y, Liang Q, Huang Q, Peng C, Xu J, Guo G, Yang G, Chen L, Xun Y, Du J, Ma X, Zhang X, Gu L. PMID: 42431710 [PubMed - in process]
	Acute toxicity and quality of life with stereotactic body radiotherapy versus conventional fractionated intensity-modulated radiotherapy to the prostate and pelvis in high-risk prostate cancer (SRAM): A randomized phase II trial. Int J Radiat Oncol Biol Phys Poon DM, Wong K, Lam D, Johnson D, Chan L, Chu CM, Ng CF, Mo F, Chan AT, Mok T. PMID: 42431329 [PubMed - as supplied by publisher]
	Joint modelling of PSA dynamics and prostate cancer risks: A population-based study in men without prior prostate cancer. PLoS One Akynkozhayev B, Christoffersen B, Lantz A, Nordström T, Humphreys K, Clements M. PMID: 42430430 [PubMed - indexed for MEDLINE]
	Evaluating a Tailored Web-Based eHealth Intervention for Symptom Management in Couples Managing Prostate Cancer During the COVID-19 Pandemic: Randomized Clinical Trial. J Med Internet Res Song L, Rini C, Zhang Y, Ma C, Northouse L, Nielsen ME, Tan X, Chen RC. PMID: 42430132 [PubMed - indexed for MEDLINE]
	Moderately hypofractionated intensity-modulated radiation therapy for intermediate- or high-risk prostate cancer: five-year results from a single-institution study in Japan. Int J Clin Oncol Anno W, Aoki S, Kunogi H, Ogura Y, Kamima T, Kozuka T, Numao N, Ebara T, Yonese J, Yoshioka Y. PMID: 42430105 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Outcomes of Neoadjuvant Radiotherapy Followed by Robotic Radical Prostatectomy in High-Risk Locally Advanced Prostate Cancer: A Prospective Pilot Study. Ann Surg Oncol Tseng CS, Chang CK, Li HJ, Liu YT, Huang SW, Huang CY, Cheng JC. PMID: 42429901 [PubMed - as supplied by publisher]
	Real-World Use of Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma in Japan: Treatment Patterns, Effectiveness, and Safety. Int J Urol Kikuchi E, Kobayashi T, Shono M, Hoffman J, Kitamura H. PMID: 42429125 [PubMed - indexed for MEDLINE]
	Haematological, renal and hepatic toxicity profiles of infusional 5-fluorouracil versus capecitabine in African gastrointestinal cancer patients: a retrospective cohort study. Ecancermedicalscience Mazhindu TA, Ndlovu N, Borok MZ, Grimes K, Masimirembwa C. PMID: 42428813 [PubMed]
	Combining VEGFR tyrosine kinase inhibitors and PD-1/PD-L1 inhibitors versus VEGFR tyrosine kinase inhibitors monotherapy in renal cell carcinoma: a target trial emulation. medRxiv Shi D, Li X, Chen Y, Chen Y, Song Q, Su J. PMID: 42428070 [PubMed - in process]
	A genome-wide Mendelian randomization study focusing on endoplasmic reticulum stress reveals novel genetic markers for renal cell carcinoma. Oncol Lett Gao B, Li Z, Shi J, Shen J. PMID: 42427927 [PubMed]
	Integration of sarcopenia screening into radiotherapy planning: Validation of a time-efficient SMI measurement method using MIM software in prostate cancer. J Appl Clin Med Phys De Bruyn P, Coquelet N, Ferreira P, Michel M, Descamps T, Van den Begin R, Van Gestel D, Preiser JC. PMID: 42427162 [PubMed - indexed for MEDLINE]
	Added value of PHI in predicting lymph node invasion in prostate cancer: an external validation. BMC Urol Fu J, Zhou X, Liu Y, Deng H, Lyu H, Chen Z. PMID: 42426730 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 179909

Seite 1 von 8996

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung